United Kingdom· GB-APID-24575811000001101
Olysio 150mg capsules
A simeprevir product containing simeprevir, registered in United Kingdom by Janssen-Cilag Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Simeprevir is registered in 2 of 19 countries.
Countries holding a registration under ATC J05AP05 (simeprevir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Simeprevir · ATC J05AP05
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Simeprevir
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AP05
- ATC class
- Simeprevir
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012674902585
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for simeprevir.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Simeprevir · interactions on record
63 records
- 21 severe
- 40 moderate
- 2 minor
Most severe, free to view
- CisaprideA03FA02severe
- EluxadolineA07DA06severe
- EdoxabanB01AF03severe
- RosuvastatinC10AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Simeprevir in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a0714ac5-ff6b-4973-9f04-aa6e723f7739 GET /v1/drugs/a0714ac5-ff6b-4973-9f04-aa6e723f7739?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "24575811000001101",
"desc": "Olysio 150mg capsules (Janssen-Cilag Ltd)",
"form": "Oral capsule",
"vpid": "24611011000001106",
"source": "dmd",
"vtm_id": "777533003",
"strength": "150 mg",
"substance": "Simeprevir",
"ingredient": "Simeprevir sodium",
"supplier_code": "2422501000001106"
}See everything about simeprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.